Chemical formula: C₁₄H₉Cl₃N₂OS Molecular mass: 359.65 g/mol PubChem compound: 50248
Triclabendazole is an anthelmintic against Fasciola species, used for the treatment of fascioliasis.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| P02BX04 | Triclabendazole | P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BX Other antitrematodal agents |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| EGATEN Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Triclabendazole is an active ingredient of these brands:
United States (US)France (FR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
